Robert R. Bies, PharmD
- 3Articles
- 11.5KReads1
- 2014–2016Active
- 11Collaborators
- 46Citations2
About
Robert R. Bies, PharmD, has published research on schizophrenia and schizoaffective disorders, focusing on antipsychotic medication dosing strategies. His work includes studies on dose adjustments of olanzapine and risperidone in patients with schizophrenia, as well as the effects of once- versus twice-daily perphenazine dosing on clinical outcomes. Bies has collaborated with co-authors such as Hiroyuki Uchida, Takefumi Suzuki, and Gary Remington.
Publications
Increasing Versus Maintaining the Dose of Olanzapine or Risperidone in Schizophrenia Patients Who Did Not Respond to a Modest Dosage: A Double-Blind Randomized Controlled Trial
October 26, 2016
1 Read counts for articles published before 2020 may include some non-human traffic.
2 Citation counts provided by Crossref.
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
